Your browser doesn't support javascript.
loading
Spontaneous remission in adult patients with IgA nephropathy treated with conservative therapy.
Sato, Hirotaka; Ichikawa, Daisuke; Okada, Eri; Suzuki, Tomo; Watanabe, Shiika; Shirai, Sayuri; Shibagaki, Yugo.
Affiliation
  • Sato H; Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan.
  • Ichikawa D; Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan.
  • Okada E; Kidney Center, National Hospital Organization Chiba-East Hospital, Chiba, Japan.
  • Suzuki T; Department of Nephrology, Kameda Medical Center, Chiba, Japan.
  • Watanabe S; Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan.
  • Shirai S; Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Yokohama City Seibu Hospital, Kanagawa, Japan.
  • Shibagaki Y; Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan.
PLoS One ; 16(5): e0251294, 2021.
Article in En | MEDLINE | ID: mdl-34043669
ABSTRACT

BACKGROUND:

There are few studies describing the clinical course and spontaneous remission of IgA nephropathy (IgAN) in adult patients receiving conservative treatment.

METHOD:

Data from 62 adult patients with biopsy-diagnosed IgAN, who received conservative treatment at least 5 years prior, were retrospectively investigated. No patients received corticosteroids, other immunosuppressants, or tonsillectomy. Remission of proteinuria and hematuria were defined as proteinuria <0.3 g/gCr and urine red blood cells (RBC) <5 / high power field (HPF) on three consecutive urinalyses obtained during an observation period of ≥6 months.

RESULT:

Thirty-eight (61.3%) patients had remission of hematuria, 24 (38.7%) had remission of proteinuria, and 19 (30.6%) had remission of both. Remission rates increased in patients with proteinuria <0.5 g/g Cr at diagnosis. The median time to remission of hematuria was 2.8 years and that of proteinuria was 2.6 years. Patients who showed renal function decline (defined as 30% decline of estimated glomerular filtration rate [eGFR] from baseline) were older, had significantly lower eGFR, and higher proteinuria at diagnosis. Two patients with preserved renal function and normal proteinuria at diagnosis experienced renal function decline. Renal function did not decline within 3 years of diagnosis in patients with proteinuria <1 g/gCr at diagnosis.

CONCLUSIONS:

Relatively high rates of spontaneous remission were observed. Remission of both hematuria and proteinuria were frequent within 3 years after diagnosis, and renal function was well preserved during this period. These data indicate that it is rational to use conservative treatment for 3 years after the diagnosis instead of aggressive treatments.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glomerulonephritis, IGA Type of study: Observational_studies Limits: Adult / Female / Humans / Male Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2021 Type: Article Affiliation country: Japan

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glomerulonephritis, IGA Type of study: Observational_studies Limits: Adult / Female / Humans / Male Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2021 Type: Article Affiliation country: Japan